Literature DB >> 8023938

Regulation of intracellular pH by immortalized human intrahepatic biliary epithelial cell lines.

S A Grubman1, R D Perrone, D W Lee, S L Murray, L C Rogers, L I Wolkoff, A E Mulberg, V Cherington, D M Jefferson.   

Abstract

We have produced continuous cell lines using retroviral transduction of SV40 large T antigen into human intrahepatic biliary epithelial (IBE) cells from three different normal individuals. These IBE cell lines grow in a hormone-supplemented medium in the presence of NIH/3T3 fibroblast coculture. These cells maintain their epithelial appearance and are positive for the biliary-specific markers cytokeratins 7 and 19 and gamma-glutamyl transpeptidase while being negative for the hepatocyte markers albumin and asialoglycoprotein receptor. To evaluate ion transport pathways in IBE cell lines, we utilized intracellular pH (pHi) measurements obtained using the intracellular fluorescent indicator 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein. In the absence of HCO3(-)-CO2, an amiloride-sensitive Na(+)-H+ exchanger participated in the regulation of basal pHi. In the presence of HCO3(-)-CO2, a 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid (DIDS)-sensitive, Na-, Cl-, and HCO3(-)-dependent acid extrusion mechanism accounted for approximately 60% of pHi recovery from acidic pHi; this mechanism is most consistent with the presence of a Na-dependent Cl-HCO3- exchanger (Na+HCO3(-)-Cl-H+). Under basal conditions, Cl- depletion revealed a DIDS-sensitive alkalinization consistent with a Na-independent Cl(-)-HCO3- exchanger. These model systems will allow the opportunity to study the normal mechanisms of IBE function and to study the pathobiology of IBE processes in disease states.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8023938     DOI: 10.1152/ajpgi.1994.266.6.G1060

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  103 in total

1.  Cholangiocyte myosin IIB is required for localized aggregation of sodium glucose cotransporter 1 to sites of Cryptosporidium parvum cellular invasion and facilitates parasite internalization.

Authors:  Steven P O'Hara; Gabriella B Gajdos; Christy E Trussoni; Patrick L Splinter; Nicholas F LaRusso
Journal:  Infect Immun       Date:  2010-05-10       Impact factor: 3.441

2.  Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasion.

Authors:  Sharon DeMorrow; Paolo Onori; Julie Venter; Pietro Invernizzi; Gabriel Frampton; Mellanie White; Antonio Franchitto; Shelley Kopriva; Francesca Bernuzzi; Heather Francis; Monique Coufal; Shannon Glaser; Giammarco Fava; Fanyin Meng; Domenico Alvaro; Guido Carpino; Eugenio Gaudio; Gianfranco Alpini
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-26       Impact factor: 4.249

3.  miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma.

Authors:  Nataliya Razumilava; Steve F Bronk; Rory L Smoot; Christian D Fingas; Nathan W Werneburg; Lewis R Roberts; Justin L Mott
Journal:  Hepatology       Date:  2011-12-19       Impact factor: 17.425

4.  The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism.

Authors:  Steven P O'Hara; Aaron J Small; Jeremy B Nelson; Andrew D Badley; Xian-Ming Chen; Gregory J Gores; Nicholas F Larusso
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Interleukin-6-driven progranulin expression increases cholangiocarcinoma growth by an Akt-dependent mechanism.

Authors:  Gabriel Frampton; Pietro Invernizzi; Francesca Bernuzzi; Hae Yong Pae; Matthew Quinn; Darijana Horvat; Cheryl Galindo; Li Huang; Matthew McMillin; Brandon Cooper; Lorenza Rimassa; Sharon DeMorrow
Journal:  Gut       Date:  2011-11-07       Impact factor: 23.059

6.  Cholangiocyte N-Ras protein mediates lipopolysaccharide-induced interleukin 6 secretion and proliferation.

Authors:  Steven P O'Hara; Patrick L Splinter; Christy E Trussoni; Gabriella B Gajdos; Pooja N Lineswala; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

7.  Biliary Epithelial Cells Are Not the Predominant Source of Hepatic CXCL12.

Authors:  Yedidya Saiman; Tatsuki Sugiyama; Noa Simchoni; Carlo Spirli; Meena B Bansal
Journal:  Am J Pathol       Date:  2015-04-29       Impact factor: 4.307

8.  Activated cholangiocytes release macrophage-polarizing extracellular vesicles bearing the DAMP S100A11.

Authors:  Tomohiro Katsumi; Maria Eugenia Guicciardi; Adiba Azad; Steven F Bronk; Anuradha Krishnan; Gregory J Gores
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-31       Impact factor: 4.249

9.  Gene-disease associations identify a connectome with shared molecular pathways in human cholangiopathies.

Authors:  Zhenhua Luo; Anil G Jegga; Jorge A Bezerra
Journal:  Hepatology       Date:  2018-01-02       Impact factor: 17.425

10.  NFkappaB p50-CCAAT/enhancer-binding protein beta (C/EBPbeta)-mediated transcriptional repression of microRNA let-7i following microbial infection.

Authors:  Steven P O'Hara; Patrick L Splinter; Gabriella B Gajdos; Christy E Trussoni; Martin E Fernandez-Zapico; Xian-Ming Chen; Nicholas F LaRusso
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.